Beyond the basics: rethinking antimicrobial stewardship by targeting cytomegalovirus immune globulin for immunocompromised patients
Identifying actionable stewardship targets in immunocompromised patients is challenging due to limited data and high morbidity. One approach could be targeting therapy with limited evidence, like cytomegalovirus immune globulin (CMV-IGIV). We implemented a drug restriction program that increased appropriate use of CMV-IGIV, highlighting a unique stewardship opportunity in immunocompromised populations.
Authors
- Joanna Nelson (ORCID: https://orcid.org/0000-0003-2152-2847)
- Marisa Holubar (ORCID: https://orcid.org/0000-0002-7585-1809)
- Gundeep Dhillon (ORCID: https://orcid.org/0000-0003-0440-1138)
- Ritika Prasad (ORCID: https://orcid.org/0000-0002-8553-7119)
- William Alegria
- Emily Mui
- Brian Lu (ORCID: https://orcid.org/0000-0002-4963-3373)
- Stanley C. Deresinski
- Daniella Veloria
Institutions
- Stanford Health Care (US)
- Stanford University (US)
Publication Details
- Journal
- Antimicrobial Stewardship & Healthcare Epidemiology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1017/ash.2025.10074
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00